Live Breaking News & Updates on Pharmaniaga lifescience sdn bhd
Stay updated with breaking news from Pharmaniaga lifescience sdn bhd. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
PETALING JAYA: Malaysia has secured deals to acquire 18.4 million doses of Covid-19 vaccines through Pharmaniaga Bhd . In separate announcements, Pharmaniaga said it would be supplying 12 million doses of Covid-19 vaccines developed by China’s Sinovac Life Sciences Co Ltd, while Duopharma said it would supply 6.4 million doses of Sputnik V developed by Russia’s Gamaleya Research Institute to the government. Both companies yesterday said they had entered into a term sheet agreements to supply the Covid-19 vaccines to the Health Ministry. Pharmaniaga said it would begin manufacturing Sinovac Covid-19 vaccines in February and will deliver the bottled vaccines to identified hospitals and other healthcare facilities nationwide by April 2021.
KUALA LUMPUR (Jan 26): Based on corporate announcements and news flow today, stocks that may be in focus tomorrow (Wednesday Jan 27) include Duopharma Biotech Bhd, Pharmaniaga Bhd, Atrium REIT, PNE PCB Bhd, Gabungan AQRS Bhd, Poh Huat Resources Holdings Bhd, Hwa Tai Industries Bhd, Chin Teck Plantations Bhd, Dagang NeXchange Bhd (DNeX), Advancecon Holdings Bhd and Tasco Bhd. Duopharma Biotech Bhd has signed a deal with the Malaysian government to supply 6.4 million doses of the Russian-developed "Sputnik V" Covid-19 vaccine. The group said it will procure and supply to the Ministry of Health (MoH) the vaccine developed by the Gamaleya National Research Institute of Epidemiology and Microbiology. Duopharma said its subsidiary, Duopharma (M) Sdn Bhd (DMSB), has signed a term sheet agreement with MoH and the Russian Direct Investment Fund (RDIF) to secure the 6.4 million doses of Sputnik V. RDIF is the appointed marketing agent for Gamaleya for all international markets, with established partnerships in India, China, and South Korea to manufacture the vaccine. Duopharma said supply of the Sputnik V vaccine could be from any of RDIF's partners, subject to approval by MoH's National Pharmaceutical Regulatory Agency (NPRA).
MOH inks term sheet agreements with two vaccine suppliers 26 Jan 2021 / 21:35 H. KUALA LUMPUR: The Ministry of Health (MOH) today signed term sheet agreements with two vaccine suppliers, Pharmaniaga Lifescience Sdn Bhd (PLS) and Duopharma (M) Sdn Bhd for the procurement of 18.4 million doses of Covid-19 vaccine for 28.75 per cent of the Malaysian population. MOH, in a statement today said PLS would supply 12 million doses of Covid-19 CORONAVAC, SARS-COV-2 Vaccine (Vero Cell) Inactivated produced by Sinovac Life Science Co. Ltd, which would be distributed in stages beginning April. “Duopharma will supply 6.4 million doses of Sputnik V vaccine, produced by the Gamaleya Research Institute of Epidemiology and Microbiology in Russia. The vaccine is expected to be distributed in stages by end-March 2021,” it said.
Deal signed: Local firms to supply Sinovac, Gamaleya vaccines from March Published Modified26 Jan 2021, 11:48 am A - The government has signed two new agreements today that would see two local firms supply 18.4 million doses of Covid-19 vaccines to the Health Ministry, which would be enough to cover 28.75 percent of Malaysia’s population. According to a Health Ministry press release today, Pharmaniaga Lifescience Sdn Bhd would supply 12 million doses of Sinovac’s CoronaVac vaccine. The first shipments are expected in April... All Access Plan
Tuesday, 26 Jan 2021 06:57 PM MYT BY JERRY CHOONG Pharmaniaga group managing director Datuk Zulkarnain Md Eusope and Health Minister Datuk Seri Dr Adham Baba pose after signing the agreement to supply Covid-19 vaccine January 26, 2021.— Picture courtesy of Pharmaniaga Subscribe to our Telegram channel for the latest updates on news you need to know. KUALA LUMPUR, Jan 26 — The Health Ministry has signed an agreement with local pharmaceutical companies Pharmaniaga Berhad and Duopharma (M) Sdn Bhd, who will jointly supply 18.4 million doses of Covid-19 vaccines from China and Russia for Malaysia. The agreement was signed earlier today by Health Minister Datuk Seri Dr Adham Baba, with Pharmaniaga represented by its group managing director Datuk Zulkarnain Md Eusope and Duopharma by its group managing director Leonard Ariff Abdul Shatar, respectively.
KUALA LUMPUR: Pharmaniaga Bhd has entered into a term sheet agreement with the Government to supply 12 million doses of Covid-19 vaccine developed by China's Sinovac Life Sciences Co Ltd.
Health Ministry inks agreements with vaccine suppliers January 26, 2021 KUALA LUMPUR – The Ministry of Health (MOH) today signed term sheet agreements with two vaccine suppliers, Pharmaniaga Lifescience Sdn Bhd (PLS) and Duopharma (M) Sdn Bhd for the procurement of 18.4 million doses of COVID-19 vaccine for 28.75 per cent of the Malaysian population. MOH, in a statement today said PLS would supply 12 million doses of COVID-19 CORONAVAC, SARS-COV-2 Vaccine (Vero Cell) Inactivated produced by Sinovac Life Science Co. Ltd, which would be distributed in stages beginning April. Advertisement “Duopharma will supply 6.4 million doses of Sputnik V vaccine, produced by the Gamaleya Research Institute of Epidemiology and Microbiology in Russia. The vaccine is expected to be distributed in stages by end-March 2021,” it said.
Pharmaniaga Bhd said today it is in the midst of negotiation with the Ministry of Health (MoH) for the purchase of the Covid-19 vaccine from China’s Sinovac Life Sciences Co Ltd (Sinovac LS) for distribution in Malaysia.
is ready to distribute Covid-19 vaccines efficiently which are expected to be ready by the first quarter of 2021, as soon as it receives the go-ahead from the government. Group managing director Datuk Zulkarnain Md Eusope said that the government-linked company has set up a team of 400 personnel skilled in logistics and distribution in five godowns located in Selangor, Penang, Sabah and Sarawak. He said besides ensuring that the delivery is done using Just-in-Time (JIT) format to hospitals (according to capacity and vaccination schedules to be determined by the government), the company also needs to focus on the safety aspects during the process of vaccine distribution.
Pharmaniaga set to distribute vaccines efficiently, prioritising safety aspects 28 Dec 2020 / 14:16 H. Pix for representational purpose only. KUALA LUMPUR: Pharmaniaga Bhd is ready to efficiently distribute Covid-19 vaccines which are expected to be ready by the first quarter of 2021, as soon as it receives the go-ahead from the government. Group managing director Datuk Zulkarnain Md Eusope said that the government-linked company has set up a team of 400 personnel skilled in logistics and distribution in five godowns located in Selangor, Penang, Sabah and Sarawak. He said besides ensuring that the delivery is done using Just-in-Time (JIT) format to hospitals (according to capacity and vaccination schedules to be determined by the government), the company also needs to focus on the safety aspects during the process of vaccine distribution.